Cong Jin Yang
Directeur Financier/CFO chez LUYAN PHARMA CO.,LTD.
Profil
Cong Jin Yang currently works at Luyan Pharma Co., Ltd., as Chief Financial Officer, Director & Deputy GM from 2018, Sichuan Luyan-Shibo Pharmaceutical Co., Ltd., as Member-Supervisory Board, Chengdu Hechuang Western District Medical Technology Co., Ltd., as Member-Supervisory Board, and Luyan (Fujian) Group Co., Ltd., as Member-Supervisory Board.
Postes actifs de Cong Jin Yang
| Sociétés | Poste | Début |
|---|---|---|
| LUYAN PHARMA CO.,LTD. | Directeur Financier/CFO | 01/01/2012 |
Sichuan Luyan-Shibo Pharmaceutical Co., Ltd.
 Sichuan Luyan-Shibo Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Sichuan Luyan-Shibo Pharmaceutical Co., Ltd. engages in the sale of pharmaceutical products. It offers compound eosinophil-lactobacillus tablets, felodipine extended-release tablets, and terbutaline sulfate for injection. The company was founded on March 28, 2007 and is headquartered in Chengdu, China. | Directeur/Membre du Conseil | - |
Chengdu Hechuang Western District Medical Technology Co., Ltd.
 Chengdu Hechuang Western District Medical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Hechuang Western District Medical Technology Co., Ltd. engages in the research and development of natural medicines. Its business scope includes research and development of natural medicines, biochemicals and chemicals, diagnostic reagents, medical biomaterials, scientific research and medical equipment, and biotherapeutic research and biotechnology products; medical technology consulting; warehouse management services; housing leasing services; and property management services. The company was founded on August 30, 1996 and is headquartered in Chengdu, China. | Directeur/Membre du Conseil | - |
Luyan (Fujian) Group Co., Ltd.
 Luyan (Fujian) Group Co., Ltd. Real Estate DevelopmentFinance Part of Luyan Pharma Co., Ltd., Luyan (Fujian) Group Co., Ltd. provides real estate services. The private company is based in Xiamen, China. Luyan (Fujian) Group Co. was acquired by Luyan Pharma Co., Ltd. from Xiamen Maidiken Technology Co., Ltd. on October 28, 2021 for $12.36 million. The Chinese company was founded in 2002. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LUYAN PHARMA CO.,LTD. | Retail Trade |
| Entreprise privées | 3 |
|---|---|
Sichuan Luyan-Shibo Pharmaceutical Co., Ltd.
Sichuan Luyan-Shibo Pharmaceutical Co., Ltd. Medical DistributorsDistribution Services Sichuan Luyan-Shibo Pharmaceutical Co., Ltd. engages in the sale of pharmaceutical products. It offers compound eosinophil-lactobacillus tablets, felodipine extended-release tablets, and terbutaline sulfate for injection. The company was founded on March 28, 2007 and is headquartered in Chengdu, China. | Distribution Services |
Chengdu Hechuang Western District Medical Technology Co., Ltd.
Chengdu Hechuang Western District Medical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Chengdu Hechuang Western District Medical Technology Co., Ltd. engages in the research and development of natural medicines. Its business scope includes research and development of natural medicines, biochemicals and chemicals, diagnostic reagents, medical biomaterials, scientific research and medical equipment, and biotherapeutic research and biotechnology products; medical technology consulting; warehouse management services; housing leasing services; and property management services. The company was founded on August 30, 1996 and is headquartered in Chengdu, China. | Health Technology |
Luyan (Fujian) Group Co., Ltd.
Luyan (Fujian) Group Co., Ltd. Real Estate DevelopmentFinance Part of Luyan Pharma Co., Ltd., Luyan (Fujian) Group Co., Ltd. provides real estate services. The private company is based in Xiamen, China. Luyan (Fujian) Group Co. was acquired by Luyan Pharma Co., Ltd. from Xiamen Maidiken Technology Co., Ltd. on October 28, 2021 for $12.36 million. The Chinese company was founded in 2002. | Finance |
